Robert W. Cross

Best Publications

• LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

  Unknown

  718
  Citations

• The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.

  Bryan E. Jones;Patricia L. Brown-Augsburger;Kizzmekia S. Corbett;Kathryn Westendorf

  429
  Citations

• Lassa Fever in Post-Conflict Sierra Leone

  Jeffrey G. Shaffer;Donald S. Grant;John S. Schieffelin;Matt L. Boisen

  268
  Citations

• Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.

  Chad E. Mire;Benjamin A. Satterfield;Joan B. Geisbert;Krystle N. Agans

  202
  Citations

• LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

  Bryan E Jones;Patricia L Brown-Augsburger;Kizzmekia S Corbett;Kathryn Westendorf

  198
  Citations

• Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits

  James E. Robinson;Kathryn M. Hastie;Robert W. Cross;Rachael E. Yenni

  187
  Citations

• Establishment of an African green monkey model for COVID-19 and protection against re-infection.

  Courtney Woolsey;Viktoriya Borisevich;Abhishek N. Prasad;Krystle N. Agans

  183
  Citations

• Genetic Diversity and Histo-Blood Group Antigen Interactions of Rhesus Enteric Caliciviruses

  Tibor Farkas;Tibor Farkas;Robert W. Cross;Edwin Hargitt;Nicholas W. Lerche

  161
  Citations

• Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever

  Chad E Mire;Robert W Cross;Joan B Geisbert;Viktoriya Borisevich

  153
  Citations

• Post-exposure treatments for Ebola and Marburg virus infections

  Robert W. Cross;Chad E. Mire;Heinz Feldmann;Thomas W. Geisbert

  130
  Citations

• The immunomodulating V and W proteins of Nipah virus determine disease course.

  Benjamin A. Satterfield;Robert W. Cross;Karla A. Fenton;Krystle N. Agans

  112
  Citations

• A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates

  Zachary A. Bornholdt;Andrew S. Herbert;Chad E. Mire;Shihua He

  107
  Citations

• The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus.

  Robert W. Cross;Chad E. Mire;Viktoriya Borisevich;Joan B. Geisbert

  102
  Citations

• Establishment of an African green monkey model for COVID-19

  Courtney B. Woolsey;Viktoriya Borisevich;Abhishek N Prasad;Krystle N. Agans

  91
  Citations

• Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.

  Chad E Mire;Krista M Versteeg;Robert W Cross;Krystle N Agans

  91
  Citations

• Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization

  Pavlo Gilchuk;Charles D. Murin;Jacob C. Milligan;Robert W. Cross

  90
  Citations

• Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.

  J. Maximilian Fels;Daniel P. Maurer;Andrew S. Herbert;Ariel S. Wirchnianski

  84
  Citations

• A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus.

  Thomas W. Geisbert;Kathryn Bobb;Viktoriya Borisevich;Joan B. Geisbert

  83
  Citations

• Combination therapy protects macaques against advanced Marburg virus disease.

  Robert W Cross;Zachary A Bornholdt;Abhishek N Prasad;Viktoriya Borisevich

  80
  Citations

• Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.

  Robert W. Cross;Rong Xu;Demetrius Matassov;Stefan Hamm

  75
  Citations